tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aligos Therapeutics appoints Kieron Wesson as VP, head of CMC
PremiumThe FlyAligos Therapeutics appoints Kieron Wesson as VP, head of CMC
2M ago
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
Premium
The Fly
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
2M ago
Aligos Therapeutics appoints Laura Kavanaugh as VP, head of legal
Premium
The Fly
Aligos Therapeutics appoints Laura Kavanaugh as VP, head of legal
3M ago
UPS downgraded, ServiceNow upgraded: Wall Street’s top analyst calls
PremiumThe FlyUPS downgraded, ServiceNow upgraded: Wall Street’s top analyst calls
3M ago
Aligos Therapeutics initiated with a Buy at Lucid Capital
Premium
The Fly
Aligos Therapeutics initiated with a Buy at Lucid Capital
3M ago
Promising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
Premium
Ratings
Promising Clinical Data and Strategic Milestones Drive Buy Rating for Aligos Therapeutics
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
Premium
Company Announcements
Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
5M ago
Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
Premium
The Fly
Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100